People · Operator
Named in public records as an officer, director or promoter · active 2020–2025 · Other Health Care, Biotechnology, AI / ML
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Exo Imaging, Inc. | — | Other Health Care | Series C | $169.6M | $284.6M | 2020 |
| OncoResponse Inc | — | Biotechnology | Series C | $109.0M | $39.4M | 2021 |
| Neural Analytics, Inc. | — | AI / ML | Series B | $81.8M | $258.0M | 2021 |
| ImmunoGenesis, Inc. | — | Biotechnology | Series C | $50.2M | $43.0M | 2024 |
TED KOUTOUZIS at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside TED KOUTOUZIS on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Clifford Stocks | 2 | 5 |
| Steven Gillis | 1 | 23 |
| Wende Hutton | 1 | 16 |
| Andrew Perlman | 1 | 15 |
| Steve Gillis | 1 | 13 |
| Yuri Pikover | 1 | 9 |
| John Donovan | 1 | 8 |
| Geeta Vemuri | 1 | 7 |
| Robert Stein | 1 | 6 |
| John McKearn | 1 | 6 |
| Zach Scheiner | 1 | 6 |
| Juan-Pablo Mas | 1 | 5 |
| Robert B. Stein | 1 | 5 |
| NEAL BHADKAMKAR | 1 | 4 |
| Thomas Barton | 1 | 4 |
| Leo Petrossian | 1 | 3 |
| Jeremy Sohn | 1 | 3 |
| Kenneth Baker | 1 | 3 |
| Roy Doumani | 1 | 3 |
| ERIC KING | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.